CASP3 and neuroblastoma: Overall, combination treatments led to greater caspase 3/7 activity in p53 wt neuroblastoma cells compared to vehicle control and single treatment alone, suggesting enhanced tumour cell killing (Figure 4C and Supplementary Figure 4C).